Department of Joint Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China.
J Orthop Surg Res. 2020 Sep 11;15(1):403. doi: 10.1186/s13018-020-01919-9.
This study aimed to evaluate the clinical efficacy of platelet-rich plasma (PRP) injection compared with hyaluronic acid (HA) injection for patients undergoing knee osteoarthritis.
We systematically searched electronic databases including PubMed, Embase, Web of Science, and the Cochrane Library on January 23, 2020 to identify relevant studies issued in English languages. The outcomes evaluating the efficacy of knee osteoarthritis (KOA) treatment were Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores (WOMAC pain, function, stiffness, and total scores) at 1, 3, 6, and 12 months; International Knee Documentation Committee (IKDC) scores, Lequesne Index score, Visual Analog Scale (VAS) scores, EQ-VAS scores, and KOOS scores. The pooled data were analyzed by Stata 12.0.
A total of 20 RCTs were enrolled in the present meta-analysis. The pooled results demonstrated that platelet-rich plasma (PRP) injection reduced pain more effectively than hyaluronic acid (HA) injection at 6-month and 12-month follow-up evaluated by WOMAC pain scores and VAS scores. EQ-VAS in the patients treated with PRP injection was lower than that in patients with HA injection at 12 months. Moreover, the patients with PRP injection had a better function recovery than those with HA injection at 1-month, 3-month, 6-month, and 12-month follow-up, as evaluated by WOMAC function scores. WOMAC total scores showed significant difference at 6-month and 12-month follow-up. The IKDC scores indicated PRP injection was significantly more effective than HA injection at 3 months and 6 months. However, the Lequesne Index scores, KOOS scores, and adverse events did not show any significant difference between groups.
Intra-articular PRP injection appeared to be more efficacious than HA injection for the treatment of KOA in terms of short-term functional recovery. Moreover, PRP injection was superior to HA injection in terms of long-term pain relief and function improvement. In addition, PRP injection did not increase the risk of adverse events compared to HA injection.
本研究旨在评估富血小板血浆(PRP)注射与透明质酸(HA)注射治疗膝骨关节炎患者的临床疗效。
我们于 2020 年 1 月 23 日系统地检索了电子数据库,包括 PubMed、Embase、Web of Science 和 Cochrane Library,以确定以英文发表的相关研究。评估膝骨关节炎(KOA)治疗效果的结局指标包括:WOMAC(WOMAC 疼痛、功能、僵硬和总分)评分在 1、3、6 和 12 个月时;国际膝关节文献委员会(IKDC)评分、Lequesne 指数评分、视觉模拟评分(VAS)、EQ-VAS 评分和 KOOS 评分。使用 Stata 12.0 软件对汇总数据进行分析。
本 meta 分析共纳入 20 项 RCT。汇总结果表明,在 6 个月和 12 个月随访时,与透明质酸(HA)注射相比,富血小板血浆(PRP)注射在 WOMAC 疼痛评分和 VAS 评分方面能更有效地减轻疼痛。在 12 个月时,接受 PRP 注射的患者的 EQ-VAS 评分低于接受 HA 注射的患者。此外,在 1 个月、3 个月、6 个月和 12 个月随访时,接受 PRP 注射的患者在 WOMAC 功能评分方面功能恢复更好。WOMAC 总分在 6 个月和 12 个月随访时差异有统计学意义。IKDC 评分表明,在 3 个月和 6 个月时,PRP 注射明显优于 HA 注射。然而,Lequesne 指数评分、KOOS 评分和不良反应在两组之间无显著差异。
在短期功能恢复方面,关节内 PRP 注射似乎比 HA 注射更有效治疗 KOA。此外,PRP 注射在长期缓解疼痛和改善功能方面优于 HA 注射。此外,与 HA 注射相比,PRP 注射并未增加不良事件的风险。